Vitrolife AB (publ)

VITR.ST · Stockholm Stock Exchange · SEK

118,30SEK

+0,10 (+0,08 %)Stand 11. Nov., 16:16

Vortag 118,20

Kennzahlen

Eröffnung
118,20
Vortag
118,20
Tagesspanne
116,30 – 119,00
52 Wochen
84,00 – 152,50
Volumen
131.030
Ø Volumen
220.861
Börsenwert
15,7 Mrd. SEK
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
1,7
Nächste Zahlen
–

Finanzen

Gerade nicht verfügbar.

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

Vitrolife AB (publ) is a medical technology company specializing in the development, production, and global sale of products for assisted reproduction. Their comprehensive offering includes a variety of essential tools for fertility treatments, such as oocyte retrieval needles, sperm processing solutions, specialized in vitro fertilization media and oils, and micromanipulation pipettes. The company also provides general labware, incubators, cryopreservation products, and systems for preimplantation genetic testing. Furthermore, Vitrolife delivers advanced equipment, including the EmbryoScope and Primo Vision time-lapse systems, along with dedicated dishes and evaluation software for these platforms. Their technology portfolio extends to Octax laser and imaging systems, as well as environmental monitoring solutions like log and guard systems and wireless sensors. With its headquarters located in Gothenburg, Sweden, Vitrolife maintains a significant international presence, operating across Europe, the Middle East, and Africa; Asia; Japan and the Pacific; and both North and South America. Founded in 1994, the company was initially known as Scandinavian IVF Science before officially changing its name to Vitrolife AB (publ) in 1998.

CEO
Rickard Ericsson
Mitarbeitende
1.088
Hauptsitz
Gothenburg, VG, SE
Sektor
Healthcare
Branche
Medical - Devices
Börsengang
28. Juni 2001

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.